Rodman & Renshaw acted as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNPR:
- Monopar Therapeutics announces common stock offering, no amount given
- Monopar Therapeutics Secures License for Wilson Disease Treatment
- Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
- Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
- Monopar Therapeutics presents data from radiopharma program based on MNPR-101